Work

Improvements in Lymphoma Symptoms and Health-Related Quality of Life in Patients with Relapsed or Refractory Large B-Cell Lymphoma Treated with Subcutaneous Epcoritamab (EPCORE NHL-1)

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-159544

Authors: Tycel Phillips, Pieternella Lugtenburg, Anupama Kalsekar, Alex Mutebi, Anthony Wang, Julie Blaedel, Katherine Kosa, Susan Martin, Mariana Sacchi, Catherine Thieblemont

Institutions: University of Michigan, U-M Rogel Cancer Center, Erasmus MC, Erasmus MC Cancer Institute, Genmab (United States), AbbVie (United States), RTI Health Solutions, Sorbonne Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310161035

FWCI: 0.68

Cites:

Cited by: 4

Related to: 10